Show Summary Details

Page of

PRINTED FROM OXFORD HANDBOOKS ONLINE ( © Oxford University Press, 2018. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Handbooks Online for personal use (for details see Privacy Policy and Legal Notice).

date: 08 December 2019

Abstract and Keywords

This chapter reviews the limited studies relevant to psychopharmacology in children and adolescents with eating disorders and discusses approaches to treating comorbid diagnoses. Promising research in neuroscience is presented and future directions that may lead to more effective interventions are discussed. No randomized controlled trials demonstrate efficacy for any psychotropic medication for children or adolescents with eating disorders. All medications used in children and adolescents specifically for treatment of an eating disorder are considered “off-label” as there are no medications approved by the U.S. Food and Drug Administration (FDA) for this use in this population. Severe food restriction and emaciation, or binge eating and purging during periods of critical brain development may alter brain function permanently and make recovery challenging. There is insufficient evidence at this time to support prescribing selective serotonin reuptake inhibitors (SSRIs) or atypical neuroleptics for the treatment of anorexia nervosa, and evidence for efficacy of SSRIs for bulimia nervosa exists only for adults.

Keywords: Psychopharmacology, eating disorders, child and adolescent, comorbid diagnoses, anorexia nervosa, bulimia nervosa, neuroimaging, genetics

Access to the complete content on Oxford Handbooks Online requires a subscription or purchase. Public users are able to search the site and view the abstracts and keywords for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can''t find the answer there, please contact us.